On June 14, 2023, FDA published a new Guidance entitled “Content of Premarket Submissions for Device Software Functions.” This document replaces FDA’s Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices, which was issued on May 11, 2005, and provides updates regarding FDA’s thoughts related to the documentation recommended by the FDA for inclusion in premarket submissions for its review of device software functions.